Neurofibromatosis Type Ii
📧 Sign up to get email alerts when something new happens for Neurofibromatosis Type Ii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II [Phase 1, Phase 2]
This clinical trial entry outlines a Phase 1/2 study to determine the optimal dose and evaluate the safety and efficacy of PRG-N-01 in patie…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 [Phase 2]
This document reports the results of a Phase II trial of everolimus (RAD001) in children and adults with Neurofibromatosis Type 2; the study…